Skip to content
10-Q

Quarterly Report

ALDER BIOPHARMACEUTICALS INC

0001564590-19-029315

← back to feed
Filed
Aug 6, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Aug 2, 2019 83.64M sh
Capex Q2 2019 · Jun 30, 2019 $1.04M
Capex Q2 2019 · Jun 30, 2018 $277K
Operating Cash Flow Q2 2019 · Jun 30, 2019 −$133.87M
Operating Cash Flow Q2 2019 · Jun 30, 2018 −$126.53M
Long Term Debt Q2 2019 · Jun 30, 2019 $188.32M
Cash And Equivalents Q2 2019 · Jun 30, 2019 $88.38M
Cash And Equivalents Q2 2019 · Dec 31, 2018 $87.87M
Stockholders Equity Q2 2019 · Jun 30, 2019 $110.31M
Stockholders Equity Q2 2019 · Dec 31, 2018 $109.98M
Stockholders Equity Q2 2019 · Jun 30, 2018 $239.67M
Stockholders Equity Q2 2019 · Dec 31, 2017 $279.28M
Current Liabilities Q2 2019 · Jun 30, 2019 $50.53M
Current Liabilities Q2 2019 · Dec 31, 2018 $28.24M
Total Liabilities Q2 2019 · Jun 30, 2019 $245.72M
Total Liabilities Q2 2019 · Dec 31, 2018 $212.51M
Current Assets Q2 2019 · Jun 30, 2019 $451.67M
Current Assets Q2 2019 · Dec 31, 2018 $419.81M
Total Assets Q2 2019 · Jun 30, 2019 $462.57M
Total Assets Q2 2019 · Dec 31, 2018 $426.24M
Sga Expense Q2 2019 · Jun 30, 2019 $21.63M
Sga Expense Q2 2019 · Jun 30, 2019 $66.13M
Sga Expense restated Q2 2019 · Jun 30, 2018 $11.91M
Sga Expense restated Q2 2019 · Jun 30, 2018 $23.46M
Rd Expense Q2 2019 · Jun 30, 2019 $34.13M
Rd Expense Q2 2019 · Jun 30, 2019 $103.71M
Rd Expense Q2 2019 · Jun 30, 2018 $52.82M
Rd Expense Q2 2019 · Jun 30, 2018 $126.87M
Net Income Q2 2019 · Jun 30, 2019 −$58.41M
Net Income Q2 2019 · Jun 30, 2019 −$176.35M
Net Income Q2 2019 · Jun 30, 2018 −$68.39M
Net Income Q2 2019 · Jun 30, 2018 −$155.42M
Operating Income Q2 2019 · Jun 30, 2019 −$55.76M
Operating Income Q2 2019 · Jun 30, 2019 −$169.85M
Operating Income restated Q2 2019 · Jun 30, 2018 −$64.73M
Operating Income restated Q2 2019 · Jun 30, 2018 −$150.33M
Revenue Q2 2019 · Jun 30, 2019 $0
Revenue Q2 2019 · Jun 30, 2019 $0
Revenue Q2 2019 · Jun 30, 2018 $0
Revenue Q2 2019 · Jun 30, 2018 $0